Literature DB >> 33603014

The implications of subretinal fluid in pachychoroid neovasculopathy.

Geun Woo Lee1,2, Hyeon Cheol Roh1, Se Woong Kang3, A Young Kim1, Hoon Noh1, Kyung Jun Choi1.   

Abstract

This study aimed to identify the clinical characteristics and longitudinal changes in exudative pachychoroid neovasculopathy (PNV) and non-exudative PNV. This retrospective cohort study involved 81 eyes of PNV diagnosed by multimodal imaging including optical coherence tomography angiography. At baseline, they were divided into exudative PNV group and non-exudative PNV group depending on the presence of subretinal fluid. The clinical features of both groups and the longitudinal changes were investigated and compared. There were 55 eyes with non-exudative PNV and 26 eyes with exudative PNV. Individuals with non-exudative PNV were older, more frequently asymptomatic and had a higher prevalence of polypoidal choroidal vasculopathy in the opposite eye (all P's < 0.05). Whereas individuals with exudative PNV showed thicker choroid and more frequent history of central serous chorioretinopathy (all P's < 0.001). During about 12 months of longitudinal observation, the transformation into polypoidal choroidal vasculopathy was noted in 4 eyes of non-exudative PNV group, whereas in none of the exudative PNV group. Exudative PNV and non-exudative PNV seem to be separate entities with different epidemiological parameters. Non-exudative PNV, which is frequently found without symptoms at an older age, is suspected to be the significant precursor lesion of polypoidal choroidal vasculopathy. In contrast, exudative PNV may share the same pathophysiology as central serous chorioretinopathy.

Entities:  

Mesh:

Year:  2021        PMID: 33603014      PMCID: PMC7892557          DOI: 10.1038/s41598-021-83650-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  24 in total

1.  Central serous chorioretinopathy in elderly subjects: angiographic and tomographic characteristics.

Authors:  Kunho Bae; Seung Wan Nam; Se Woong Kang; Eung Suk Kim; Seung-Young Yu; Kyung Tae Kim; Sang Jin Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-12-18       Impact factor: 3.117

2.  ONE-YEAR RESULTS OF ADJUNCTIVE PHOTODYNAMIC THERAPY FOR TYPE 1 NEOVASCULARIZATION ASSOCIATED WITH THICKENED CHOROID.

Authors:  Jae Hyung Lee; Won Ki Lee
Journal:  Retina       Date:  2016-05       Impact factor: 4.256

3.  Changes in Choroidal Thickness After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor in Pachychoroid Neovasculopathy.

Authors:  Noel Padrón-Pérez; Luis Arias; Marcos Rubio; Daniel Lorenzo; Pere García-Bru; Jaume Català-Mora; José M Caminal
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-02-01       Impact factor: 4.799

4.  En face imaging of the choroid in polypoidal choroidal vasculopathy using swept-source optical coherence tomography.

Authors:  Tarek Alasil; Daniela Ferrara; Mehreen Adhi; Erika Brewer; Martin F Kraus; Caroline R Baumal; Joachim Hornegger; James G Fujimoto; Andre J Witkin; Elias Reichel; Jay S Duker; Nadia K Waheed
Journal:  Am J Ophthalmol       Date:  2014-12-19       Impact factor: 5.258

5.  The use of optical coherence tomography angiography in pachychoroid spectrum diseases: a concurrent comparison with dye angiography.

Authors:  Sibel Demirel; Özge Yanık; Hilal Nalcı; Figen Batıoğlu; Emin Özmert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-09-11       Impact factor: 3.117

6.  Response of neovascular central serous chorioretinopathy to an extended upload of anti-VEGF agents.

Authors:  Benedikt Schworm; Nikolaus Luft; Leonie F Keidel; Felix Hagenau; Christoph Kern; Tina Herold; Karsten U Kortuem; Siegfried G Priglinger; Jakob Siedlecki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-02-28       Impact factor: 3.117

7.  Pachychoroid pigment epitheliopathy.

Authors:  David J Warrow; Quan V Hoang; K Bailey Freund
Journal:  Retina       Date:  2013-09       Impact factor: 4.256

8.  Polypoidal choroidal vasculopathy and late geographic hyperfluorescence on indocyanine green angiography.

Authors:  S W Kang; S E Chung; W J Shin; J-H Lee
Journal:  Br J Ophthalmol       Date:  2009-03-19       Impact factor: 4.638

9.  Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy.

Authors:  Byung Ju Jung; Joo Young Kim; Jae Hyung Lee; Jiwon Baek; Kook Lee; Won Ki Lee
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

Review 10.  Pachychoroid disease.

Authors:  Chui Ming Gemmy Cheung; Won Ki Lee; Hideki Koizumi; Kunal Dansingani; Timothy Y Y Lai; K Bailey Freund
Journal:  Eye (Lond)       Date:  2018-07-11       Impact factor: 3.775

View more
  3 in total

1.  Imaging Characteristics of Neovascular and Atrophic Pachychoroidal Spectrum Diseases.

Authors:  Rui Hua; Meixia Zhang
Journal:  Front Med (Lausanne)       Date:  2022-07-04

2.  Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up.

Authors:  Jiyang Tang; Xinyao Han; Ran Tang; Mengyang Li; Zongyi Wang; Mingwei Zhao; Jinfeng Qu
Journal:  BMC Ophthalmol       Date:  2022-06-21       Impact factor: 2.086

Review 3.  Relationship between Pachychoroid and Polypoidal Choroidal Vasculopathy.

Authors:  Kenji Yamashiro; Yasuo Yanagi; Hideki Koizumi; Hidetaka Matsumoto; Chui Ming Gemmy Cheung; Fumi Gomi; Tomohiro Iida; Akitaka Tsujikawa
Journal:  J Clin Med       Date:  2022-08-08       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.